CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced its 2024 Annual Results.
Shares of Sarepta Therapeutics have struggled for the past year due to concerns about the commercial potential of its gene ...